Nuo Therapeutics Inc

DELISTED:AURX (USA)  
(Delisted) $ 0.07 +0.04 (+133.33%) 01:57 PM EST
At Loss
P/B:
52.94
Enterprise V:
$ -553.00K
Volume:
100.00K
Avg Vol (2M):
-
Volume:
100.00K
At Loss
Avg Vol (2M):
-

Business Description

Nuo Therapeutics Inc
NAICS : 325414 SIC : 2836
ISIN : US67059V2097
Description
Nuo Therapeutics Inc is a regenerative therapies company focused on developing and marketing products for chronic wound care primarily within the U.S. Company's commercialize innovative cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing. The company derives revenues from the sale of the Aurix product to customers consisting of primarily hospital outpatient wound care clinics and other private practice physicians treating chronic wounds. The Aurix product became commercially available for sale in current financial year.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 2.11
Equity-to-Asset 0.45
Debt-to-Equity 0.38
Debt-to-EBITDA -0.08
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -5.88
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year Revenue Growth Rate -20.6
3-Year EBITDA Growth Rate -23.4
3-Year EPS without NRI Growth Rate -18.9

Momentum Rank

Name Current Vs Industry Vs History

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.84
Quick Ratio 1.53
Cash Ratio 0.85
Days Inventory 867.72
Days Sales Outstanding 103.86
Days Payable 1501.39

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -20.8
Shareholder Yield % -0.12

Financials (Next Earnings Date:2024-05-15 Est.)

DELISTED:AURX's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with DELISTED:AURX

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Nuo Therapeutics Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.524
EPS (TTM) ($) -0.75
Beta 0
Volatility % 0
14-Day RSI 0
14-Day ATR ($) 0
20-Day SMA ($) 0
12-1 Month Momentum % 0
52-Week Range ($) 0.3 - 2.5
Shares Outstanding (Mil) 19.58

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Nuo Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

Nuo Therapeutics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Nuo Therapeutics Inc Frequently Asked Questions

What is Nuo Therapeutics Inc(DELISTED:AURX)'s stock price today?
The current price of DELISTED:AURX is $0.07. The 52 week high of DELISTED:AURX is $2.50 and 52 week low is $0.30.
When is next earnings date of Nuo Therapeutics Inc(DELISTED:AURX)?
The next earnings date of Nuo Therapeutics Inc(DELISTED:AURX) is 2024-05-15 Est..
Does Nuo Therapeutics Inc(DELISTED:AURX) pay dividends? If so, how much?
Nuo Therapeutics Inc(DELISTED:AURX) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1